Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Receivables (2022 - 2025)

Historic Receivables for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to $3000.0.

  • PAVmed's Receivables changed N/A to $3000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3000.0, marking a year-over-year change of. This contributed to the annual value of $18000.0 for FY2024, which is 7049.18% down from last year.
  • According to the latest figures from Q3 2025, PAVmed's Receivables is $3000.0.
  • In the past 5 years, PAVmed's Receivables ranged from a high of $219000.0 in Q2 2024 and a low of $3000.0 during Q2 2025
  • In the last 4 years, PAVmed's Receivables had a median value of $31000.0 in 2022 and averaged $47769.2.
  • In the last 5 years, PAVmed's Receivables surged by 43414.63% in 2024 and then crashed by 9863.01% in 2025.
  • Over the past 4 years, PAVmed's Receivables (Quarter) stood at $17000.0 in 2022, then soared by 258.82% to $61000.0 in 2023, then tumbled by 70.49% to $18000.0 in 2024, then plummeted by 83.33% to $3000.0 in 2025.
  • Its last three reported values are $3000.0 in Q3 2025, $3000.0 for Q2 2025, and $9000.0 during Q1 2025.